COH and TGen Precision Medicine Symposium

Wednesday, June 13, 2018

8:00 – 8:15 AM Welcome
Robert W. Stone & Jeffrey Trent, PhD, FACMG

8:15 – 8:30 AM Kick-Off
Steven T. Rosen, MD & Linda H. Malkas, PhD

SESSION: Key to Our Success I

8:30 – 9:20 AM Evidence-based Medicine; ORIEN
Michael A. Caligiuri, MD

SESSION: Genes and Environment = YOU

9:30 – 9:50 AM Hereditary Breast Cancer Susceptibility: Defining the New Frontier
Thomas Slavin, MD

9:50 – 10:10 AM You’re More Than Your Genes
Victoria Seewaldt, MD

SESSION: Tumor Mutations Can Lead to Treatment Decisions

11:25 – 11:45 AM  Update: Planned Launch of ORIEN Avatar at COH
Larry W. Kwak, MD, PhD & Xiaoyu Xia, PhD

11:45 AM – 12:05 PM  Clinical Genomics – The CLIA Lab Perspective
Raju K. Pillai, MD

SESSION: Smarter Clinical Trials

1:10 – 1:30 PM  CAR T Cell Therapy for Hematological Malignancies
Xiuli Wang, MD, PhD

1:30 – 1:50 PM  Academic Drug Discovery: A Collaboration Between TGen and COH ~ New Cancer Therapies Via High Performance Computing
Mohan R. Kaadige, PhD

SESSION: Targeting Treatment and Response

2:10 – 2:30 PM Studying HLA-mediated Immune Pressure on Tumor Neoantigens
John Altin, PhD

SESSION: Integrated Quantitative Medicine

3:10 – 3:30 PM  Rapid Learning Systems and the Use of Personal Risk Thresholds in Patient Care
Nicholas Schork, PhD

3:30 – 3:50 PM  Building and Benefiting from a Patient-focused “Data Lake”
James Lowey, BS     

SESSION: Reaching Key Stakeholders

 4:10 – 4:30 PM  Keys to Community Implementation and Dissemination
Kathleen R. Blazer, EdD, LCGC

4:30 – 4:50 PM MindCrowd – Modernized Electronic Cohort Recruitment and Study
Matt Huentelman, PhD

5:00 – 5:15 PM Closing Remarks
Linda H. Malkas, PhD & David J. Duggan, PhD 

5:15 PM Adjourn for the Day